IPVC 2024 - Presentations from ULACNet & CASCADE

Date Posted

Presentations from the DCP-funded NCI ULACNet and CASCADE Programs at the 2024 International Papillomavirus Conference

The 36th International Papillomavirus Conference & Basic, Clinical and Public Health Scientific Workshops (IPVC 2024) will be held in Edinburgh, UK, November 12-15, 2024. The theme is “Equitable, Evidence-Based Approaches to HPV Disease,” and sessions will be available on demand after the conference for those who registered. 

Learn more at https://ipvconference.org/
 

Schedule

Tuesday, November 12, 2024
Time Topic Location
14:45 - 15:45

Public Health Workshop 03

  • Cervical cancer screening implementation issues. Methods to overcome barriers, including self-sampling, etc. - Jennifer Smith
 Pentland Auditorium
Wednesday, November 13, 2024
Time Topic Location
15:30 - 16:30 

ULACNet and CASCADE Program Meeting for IPVC Attendees

  • Vikrant V. Sahasrabuddhe, Silvina Frech, Emma Brofsky
 Menteith Room
18:15 - 19:15 Clinical Science - Poster Discussion Session 01
  • Ecological Analyses of Cervical Fungal Communities: Association with Cervical Disease Progression, HPV and Physiological Status – Filipa Godoy-Vitorino
  • HPV Vaccine Responses In Children With HIV – Ann Duerr
 Station 3
Thursday, November 14, 2024
Time Topic Location
16:00 - 17:30

Special Interest Satellite Symposium (SISS)
‘ULACNet’ And ‘CASCADE: Equitable Partnerships for Clinical Trials on Pragmatic Interventions for HPV-Related Screening and Precancer Treatment in People Living with HIV 
Chairs: Vikrant V. Sahasrabuddhe & Leeya F. Pinder

  • Foundational vision, organizational linkages, and partnership development in ‘ULACNet’ and ‘CASCADE’ – Vikrant V. Sahasrabuddhe 
  • Innovations and technologies to improve and optimize cervical and HPV-related cancer screening and triage for persons living with HIV – Luisa L. Villa 
  • Capacity building for expanding anal cancer prevention clinical care delivery and clinical research efforts for persons living with HIV – Josefina Romaguera 
  • Implementation experiences for clinical trials on cervical cancer screening, triage and precancer treatment in persons living with HIV – Bothwell T. Guzha 
  • Horizontal and diagonal integration approaches for enhancing access to HPV/cervical cancer screening – Lameck Chinula 
  • Management of multi-institutional collaborations for HPV/cancer prevention clinical trials for persons living with HIV – Carla J. Chibwesha 
  • Bridging disciplines to foster effective implementation of collaborations for HPV/cervical cancer prevention research – Gad Murenzi 
  • Evaluating novel strategies to improve precancer treatment for PLWH in ULACNet and CASCADE – Leeya F. Pinder
 Moorfoot
16:00 - 17:30

Clinical Science - Oral Abstracts Session 06

  • Improved Cervical Cancer Screening Using HPV Type Restriction and Cycle Threshold: A Prospective Screening Cohort of Women With and Without HIV In Botswana – Rebecca Luckett
 Fintry Auditorium
17:35 - 18:35 Public Health - Poster Discussion Session 02
  • Prevalence of Anal High-Risk Human Papillomavirus in ULACNet-101: A Study of People Living with HIV in Puerto Rico And Mexico – Josefina Romaguera
 Station 1

Posters (Exhibition Area)

POSTER SHIFT 1 Tuesday, November 12th - Wednesday, November 13th

Public Health, Epidemiology and Implementation Science – HPV among high risk/special populations

  • Human Papillomavirus Positivity as a Metric for HRA Performance – Sonia Hernandez-Salazar
  • Study Design of ULACNet Trial 202: Optimization of Cervical Cancer Screening Among Women Living with HIV in Latin American Countries – Kimberly Isaacs-Soriano
POSTER SHIFT 2 Thursday, November 14th - Friday, November 15th

Clinical Research – HPV tests & biomarkers for early detection and management of cervical cancer and related precursors

  • Triage of hrHPV-Positive Cervical Specimens by Host Gene Methylation in Women Living with HIV: Results from the ULACNet ROCCHHA 202 Study – Luisa Villa

Public Health, Epidemiology and Implementation Science – Epidemiology: Natural History/Risk Factors

  • Association Between Tobacco Use and Oral HPV Infection Among Men Living with HIV – Alejandra Portillo 

Public Health, Epidemiology and Implementation Science – HPV among high risk/special populations

  • Oral HPV Prevalence by Genotype Among Men with HIV in Puerto Rico, Brazil, and Mexico – Julie Rathwell
  • Prevalence of anal high-risk HPV infection among users of Condesa Clinics in Mexico City – Aarón Osvaldo Rodriguez-Ojeda
  • Cervical And Anal High-Risk HPV Infection, And Disease Status, Among Women Living With HIV in The ULACNet-CAMPO Consortium – Josefina Romaguera

Public Health, Epidemiology and Implementation Science – Screening for HPV-related disease: implementation, evaluation and impact

  • Estudio Oportunidad: A Longitudinal Study among Women Living with HIV In Santo Domingo, Dominican Republic – Margaret Madeleine